Mylan Inc  

(Public, NASDAQ:MYL)   Watch this stock  
Find more results for Mylan Technologies, Inc
+0.08 (0.14%)
Feb 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 56.89 - 58.37
52 week 44.74 - 59.60
Open 57.92
Vol / Avg. 5.23M/3.34M
Mkt cap 21.46B
P/E 24.73
Div/yield     -
EPS 2.32
Shares 374.27M
Beta 1.27
Inst. own 92%
Mar 11, 2015
Mylan Inc at Barclays Healthcare Conference - 8:30AM EDT - Add to calendar
Mar 2, 2015
Q4 2014 Mylan Inc Earnings Call - 4:30PM EST - Add to calendar
Mar 2, 2015
Q4 2014 Mylan Inc Earnings Release - 4:00PM EST - Add to calendar
Feb 2, 2015
Theravance Biopharma and Mylan Partner to Develop and Commercialize a Novel LAMA Compound, TD-4208, for COPD - Webcast
Jan 13, 2015
Mylan Inc at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 23.96% 9.07%
Operating margin 23.56% 16.80%
EBITD margin - 26.89%
Return on average assets 13.02% 4.60%
Return on average equity 59.57% 19.86%
Employees 20,000 -
CDP Score - -


United States - Map
+1-724-5141800 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Mylan Inc. (Mylan) is a global pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. Mylan operates in two segments: Generics and Specialty. The Company�s generic pharmaceutical business is conducted primarily in the United States and Canada (collectively, North America); Europe, the Middle East, and Africa (collectively, EMEA); and India, Australia, Japan and New Zealand (collectively, Asia Pacific). Its specialty pharmaceutical business is conducted by Mylan Specialty L.P. (Mylan Specialty). The Company�s API business is conducted through Mylan Laboratories Limited (Mylan India), which is included within the Asia Pacific region in its Generics Segment. Mylan provides products to customers in approximately 140 countries and territories.

Officers and directors

Robert J. Coury Executive Chairman of the Board
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Rajiv Malik President, Director
Age: 52
Bio & Compensation  - Reuters
Heather M. Bresch Chief Executive Officer, Director
Age: 44
Bio & Compensation  - Reuters
Rodney L. Piatt CPA Vice Chairman of the Board, Lead Independent Director
Age: 61
Bio & Compensation  - Reuters
John D. Sheehan CPA Executive Vice President, Chief Financial Officer, Principal Financial officer
Age: 53
Bio & Compensation  - Reuters
Rakesh Bamzai President - India Commercial and Emerging Markets
Bio & Compensation  - Reuters
Anthony Mauro President, North America
Age: 41
Bio & Compensation  - Reuters
Wendy Cameron Independent Director
Age: 54
Bio & Compensation  - Reuters
Robert J. Cindrich Independent Director
Age: 70
Bio & Compensation  - Reuters
Neil F. Dimick CPA Independent Director
Age: 65
Bio & Compensation  - Reuters